X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (38380) 38380
Newspaper Article (6260) 6260
Newsletter (315) 315
Book Chapter (314) 314
Magazine Article (161) 161
Government Document (101) 101
Trade Publication Article (71) 71
Dissertation (43) 43
Book / eBook (34) 34
Web Resource (31) 31
Book Review (11) 11
Conference Proceeding (11) 11
Report (10) 10
Publication (4) 4
Reference (1) 1
Transcript (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (29407) 29407
transplants & implants (21700) 21700
male (18434) 18434
female (17382) 17382
transplantation (16190) 16190
middle aged (13902) 13902
adult (12680) 12680
surgery (9801) 9801
aged (7454) 7454
risk factors (6699) 6699
treatment outcome (6420) 6420
patients (5878) 5878
organ transplant recipients (5827) 5827
immunology (5769) 5769
retrospective studies (5596) 5596
oncology (5224) 5224
health aspects (5213) 5213
medicine & public health (4838) 4838
kidneys (4824) 4824
adolescent (4570) 4570
stem cells (4543) 4543
kidney transplantation - adverse effects (4505) 4505
analysis (4449) 4449
kidney transplantation (4418) 4418
mortality (4289) 4289
animals (3880) 3880
care and treatment (3619) 3619
research (3495) 3495
young adult (3434) 3434
child (3358) 3358
medical equipment (3349) 3349
hematology (3342) 3342
time factors (3304) 3304
disease (3280) 3280
liver (3252) 3252
gastroenterology & hepatology (3207) 3207
follow-up studies (3164) 3164
medical research (3065) 3065
transplant recipients (3045) 3045
transplant surgery (3038) 3038
medicine (2965) 2965
hip joint (2877) 2877
recipients (2876) 2876
therapy (2858) 2858
abridged index medicus (2843) 2843
studies (2818) 2818
immunosuppressive agents - therapeutic use (2780) 2780
immunosuppression (2752) 2752
regulatory agencies (2747) 2747
immunosuppressive agents - adverse effects (2732) 2732
transplantation of organs, tissues, etc (2729) 2729
survival (2680) 2680
cancer (2658) 2658
pediatrics (2657) 2657
infections (2647) 2647
hepatology (2582) 2582
bone marrow (2556) 2556
gastroenterology (2549) 2549
infectious diseases (2336) 2336
clinical trials (2310) 2310
prognosis (2309) 2309
prospective studies (2256) 2256
biochemistry, general (2214) 2214
heart (2212) 2212
risk (2180) 2180
urology & nephrology (2158) 2158
infection (2149) 2149
children (2092) 2092
child, preschool (2071) 2071
medicine, experimental (2057) 2057
liver transplantation (2044) 2044
graft survival (2032) 2032
risk-factors (2001) 2001
diagnosis (1953) 1953
immunotherapy (1945) 1945
liver transplantation - adverse effects (1917) 1917
transplantation, homologous (1879) 1879
complications (1845) 1845
incidence (1837) 1837
chemotherapy (1834) 1834
pharmacology & pharmacy (1819) 1819
hematopoietic stem cells (1818) 1818
outcomes (1783) 1783
biopsy (1750) 1750
graft rejection (1747) 1747
tacrolimus (1738) 1738
medicine, general & internal (1733) 1733
hematopoietic stem cell transplantation - adverse effects (1714) 1714
usage (1713) 1713
cyclosporine (1660) 1660
research article (1599) 1599
management (1583) 1583
complications and side effects (1578) 1578
prevention (1578) 1578
cardiac & cardiovascular systems (1570) 1570
kidney diseases (1560) 1560
quality of life (1544) 1544
hospitals (1540) 1540
allografts (1538) 1538
diabetes (1529) 1529
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (7) 7
Online Resources - Online (5) 5
Collection Dvlpm't (Acquisitions) - Vendor file (4) 4
Collection Dvlpm't (Acquisitions) - Closed Orders (2) 2
Engineering & Comp. Sci. - Stacks (1) 1
Media Commons - Microtexts (1) 1
Scarborough Hospital - Online (1) 1
UofT at Mississauga - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (44969) 44969
French (626) 626
Portuguese (117) 117
German (107) 107
Spanish (97) 97
Japanese (39) 39
Russian (19) 19
Norwegian (16) 16
Chinese (15) 15
Polish (12) 12
Italian (10) 10
Turkish (8) 8
Korean (4) 4
Persian (4) 4
Hungarian (3) 3
Arabic (2) 2
Dutch (2) 2
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England journal of medicine, ISSN 1533-4406, 2011, Volume 365, Issue 3, pp. 203 - 212
.... BEACOPP therapy was associated with higher initial rates of complete response and freedom from relapse but also with more short-term and long-term toxic effects... 
CELL TRANSPLANT | MEDICINE, GENERAL & INTERNAL | VINORELBINE | MOPP | DISEASE | REGIMEN | IFOSFAMIDE | CHEMOTHERAPY | STANDARD | HYBRID | FERTILITY | Doxorubicin - therapeutic use | Dacarbazine - adverse effects | Dacarbazine - therapeutic use | Humans | Middle Aged | Salvage Therapy | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Vinblastine - therapeutic use | Cyclophosphamide - adverse effects | Cyclophosphamide - therapeutic use | Young Adult | Hodgkin Disease - radiotherapy | Bleomycin - therapeutic use | Vinblastine - adverse effects | Hodgkin Disease - drug therapy | Hodgkin Disease - mortality | Adult | Female | Etoposide - adverse effects | Prednisone - adverse effects | Kaplan-Meier Estimate | Proportional Hazards Models | Hematopoietic Stem Cell Transplantation | Etoposide - therapeutic use | Combined Modality Therapy | Bleomycin - adverse effects | Remission Induction | Disease-Free Survival | Procarbazine - adverse effects | Procarbazine - therapeutic use | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Hodgkin Disease - therapy | Adolescent | Vincristine - therapeutic use | Vincristine - adverse effects | Neoplasm Staging | Doxorubicin - adverse effects | Prednisone - therapeutic use | Procarbazine | Vinblastine | Disease | Etoposide | Prednisone | Family medical history | Radiation therapy | Patients | Lymphoma | Doxorubicin | Survival | Vincristine | Studies | Hepatitis | Dacarbazine | Cyclophosphamide | Chemotherapy | Bleomycin | Tomography | Lymphomas | Hodgkin's disease
Journal Article
Antimicrobial agents and chemotherapy, ISSN 1098-6596, 2012, Volume 56, Issue 9, pp. 4793 - 4799
Journal Article
Drug safety, ISSN 0114-5916, 2000, Volume 23, Issue 5, pp. 429 - 448
...).Sulfasalazine consists of sulfapyridine linked to 5-aminosalicylic acid (5-ASA) via an azo bond. Common adverse effects related to sulfapyridine intolerance include headache, nausea, anorexia, and malaise... 
Mercaptopurine, general | Inflammatory bowel disease, treatment | Salicylates, general | Ciprofloxacin, general | Cyclosporin, general | Sulfasalazine, general | Azathioprine, general | Antibacterials, general | Metronidazole, general | Methotrexate, general | Tacrolimus, general | Immunomodulators, general | Mycophenolate mofetil, general | Aminosalicylic acid, general | Corticosteroids, general | RHEUMATOID-ARTHRITIS | LONG-TERM | RENAL-ALLOGRAFT RECIPIENTS | GLUCOCORTICOID-INDUCED OSTEOPOROSIS | ACTIVE CROHNS-DISEASE | RESISTANT ULCERATIVE-COLITIS | 5-AMINOSALICYLIC ACID | PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH | DOUBLE-BLIND | PHARMACOLOGY & PHARMACY | TOXICOLOGY | PLACEBO-CONTROLLED TRIAL | MYCOPHENOLATE-MOFETIL | Anti-Infective Agents - pharmacology | Humans | Immunosuppressive Agents - therapeutic use | Male | Sulfasalazine - pharmacology | Adrenal Cortex Hormones - therapeutic use | Prodrugs - metabolism | Anti-Inflammatory Agents, Non-Steroidal - pharmacology | Female | Immunosuppressive Agents - pharmacology | Inflammatory Bowel Diseases - drug therapy | Sulfasalazine - therapeutic use | Anti-Infective Agents - adverse effects | Mesalamine - adverse effects | Adrenal Cortex Hormones - pharmacology | Anti-Infective Agents - therapeutic use | Pregnancy | Adrenal Cortex Hormones - adverse effects | Gastrointestinal Agents - pharmacology | Mesalamine - pharmacology | Anti-Inflammatory Agents, Non-Steroidal - adverse effects | Anti-Inflammatory Agents, Non-Steroidal - therapeutic use | Gastrointestinal Agents - therapeutic use | Mesalamine - therapeutic use | Immunosuppressive Agents - adverse effects | Gastrointestinal Agents - adverse effects | Sulfasalazine - adverse effects
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2014, Volume 371, Issue 10, pp. 895 - 905
.... However, since autologous stem-cell transplantation has substantial toxic effects and requires prolonged hospitalization, the comparison with less toxic, orally administered treatments is important... 
MEDICINE, GENERAL & INTERNAL | PREDNISONE | PLUS DEXAMETHASONE | INDUCTION THERAPY | LENALIDOMIDE | INITIAL TREATMENT | RANDOMIZED CONTROLLED-TRIAL | BORTEZOMIB | STEM-CELL TRANSPLANTATION | ELDERLY-PATIENTS | MELPHALAN | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Multiple Myeloma - mortality | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Transplantation, Autologous | Consolidation Chemotherapy | Antineoplastic Agents, Alkylating - administration & dosage | Thalidomide - analogs & derivatives | Multiple Myeloma - drug therapy | Multiple Myeloma - therapy | Melphalan - adverse effects | Adult | Maintenance Chemotherapy | Neutropenia - chemically induced | Thalidomide - adverse effects | Prednisone - administration & dosage | Prednisone - adverse effects | Kaplan-Meier Estimate | Combined Modality Therapy | Thalidomide - administration & dosage | Disease-Free Survival | Melphalan - administration & dosage | Aged | Antineoplastic Agents, Alkylating - adverse effects | Stem Cell Transplantation - adverse effects | Complications and side effects | Care and treatment | Patient outcomes | Multiple myeloma | Stem cells | Transplantation | Research | Health aspects | Autografts | Chemotherapy | Cell survival | Transplants & implants | Melphalan | Stem cell transplantation | Death | Prednisone | Drug dosages | Neutropenia | Index Medicus | Abridged Index Medicus
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2004, Volume 350, Issue 13, pp. 1287 - 1295
Journal Article
JAMA : the journal of the American Medical Association, ISSN 0098-7484, 01/2018, Volume 319, Issue 1, pp. 27 - 37
IMPORTANCE: Transcatheter aortic valve replacement (TAVR) is established for selected patients with severe aortic stenosis. However, limitations such as... 
MEDICINE, GENERAL & INTERNAL | IMPACT | REGURGITATION | PREDICTORS | BIOPROSTHESIS | OUTCOMES | PERMANENT PACEMAKER IMPLANTATION | END-POINT DEFINITIONS | INSIGHTS | Cardiovascular Diseases - etiology | Postoperative Complications - etiology | Follow-Up Studies | Heart Valve Prosthesis | Humans | Risk Factors | Bioprosthesis | Male | Treatment Outcome | Aortic Valve - surgery | Prosthesis Design | Aortic Valve Stenosis - mortality | Aged, 80 and over | Cardiovascular Diseases - mortality | Female | Aged | Aortic Valve Stenosis - surgery | Transcatheter Aortic Valve Replacement - mortality | Transcatheter Aortic Valve Replacement - methods | Transcatheter Aortic Valve Replacement - adverse effects | Treatment outcome | Complications and side effects | Care and treatment | Analysis | Aortic valve stenosis | Patient outcomes | Heart valve replacement | Risk factors | Conduction | Stroke | Statistical analysis | Kidneys | Transplants & implants | Risk groups | Complications | Mortality | Stenosis | Clinical trials | Risk | Data processing | Thrombosis | Patients | Catheters | Bleeding | Coronary vessels | Implants | Aorta | Safety | Thromboembolism | Aortic valve | Original Investigation | Research | Kardiologi | Clinical Medicine | Cardiac and Cardiovascular Systems | Medical and Health Sciences | Medicin och hälsovetenskap | Surgery | Klinisk medicin | Kirurgi
Journal Article
Vaccine, ISSN 0264-410X, 2016, Volume 34, Issue 3, pp. 313 - 319
...) vaccine with MF59 or saline placebo at 0, 1 and 6 months. • The vaccine was generally well tolerated, although local and systemic adverse events were significantly more common in the vaccine group... 
Allergy and Immunology | Cytomegalovirus | Vaccine | CMV gB | Adolescent | MEDICINE, RESEARCH & EXPERIMENTAL | IMMUNITY | PREVENTION | TRANSPLANT RECIPIENTS | IMMUNOLOGY | ADJUVANT | PLASMA | DNA | DISEASE | CMV INFECTION | Cytomegalovirus Vaccines - adverse effects | Adjuvants, Immunologic - administration & dosage | Vaccines, Subunit - genetics | Humans | DNA, Viral - analysis | Cytomegalovirus Infections - immunology | Vaccines, Synthetic - immunology | Cytomegalovirus Vaccines - administration & dosage | Antibodies, Viral - blood | Drug-Related Side Effects and Adverse Reactions - pathology | Adjuvants, Immunologic - adverse effects | Cytomegalovirus Infections - prevention & control | Vaccines, Synthetic - adverse effects | Blood - virology | Polymerase Chain Reaction | Polysorbates - administration & dosage | Female | Immunization Schedule | Vaccines, Subunit - adverse effects | Child | Cytomegalovirus Vaccines - genetics | Placebos - administration & dosage | Antigens, Viral - analysis | Polysorbates - adverse effects | Viral Envelope Proteins - genetics | Double-Blind Method | Vaccines, Synthetic - genetics | Squalene - administration & dosage | Urine - virology | Vaccines, Subunit - immunology | Squalene - adverse effects | Drug-Related Side Effects and Adverse Reactions - epidemiology | Vaccines, Subunit - administration & dosage | Viral Envelope Proteins - immunology | Vaccines, Synthetic - administration & dosage | DNA, Viral - genetics | Cytomegalovirus Vaccines - immunology | Clinical trials | Medical colleges | Vaccines | Teenage girls | Antigens | Cytomegalovirus infections | Vaccination | Urine | Confidence intervals | Substance abuse treatment | Consent | Hispanic Americans | Population | Infections | adolescent | vaccine | cytomegalovirus
Journal Article
Biology of blood and marrow transplantation, ISSN 1083-8791, 2013, Volume 19, Issue 1, pp. 117 - 122
Abstract Fifty patients with high-risk hematologic malignancies, underwent an unmanipulated haploidentical bone marrow transplantation (BMT), followed by... 
Hematology, Oncology and Palliative Medicine | Haploidentical transplantations | Acute leukemia | HLA | Posttransplantation cyclophosphamide | Allogeneic stem cell transplant | MORTALITY | IMMUNOLOGY | RECIPIENTS | VERSUS-HOST-DISEASE | TRANSPLANTATION | REDUCED-INTENSITY | ACUTE-LEUKEMIA | HIGH-RISK | HAPLOTYPE | OUTCOMES | STEM-CELL TRANSPLANTATION | HEMATOLOGY | BLOOD | Hematologic Neoplasms - therapy | Whole-Body Irradiation | Cyclophosphamide - administration & dosage | Follow-Up Studies | Myeloablative Agonists - adverse effects | Thiotepa - administration & dosage | Hematologic Neoplasms - mortality | Humans | Middle Aged | Male | Antineoplastic Agents - administration & dosage | Busulfan - administration & dosage | Cyclophosphamide - adverse effects | Transplantation, Homologous | Graft vs Host Disease - mortality | Antineoplastic Agents - adverse effects | Bone Marrow Transplantation | Adult | Female | Retrospective Studies | Graft vs Host Disease - etiology | Immunosuppressive Agents - administration & dosage | Acute Disease | Busulfan - adverse effects | Vidarabine - adverse effects | Survival Rate | Vidarabine - analogs & derivatives | Disease-Free Survival | Adolescent | Myeloablative Agonists - administration & dosage | Graft vs Host Disease - prevention & control | Immunosuppressive Agents - adverse effects | Aged | Vidarabine - administration & dosage | Transplantation Conditioning | Chronic Disease | Thiotepa - adverse effects | Antimitotic agents | Pneumonia | Cyclophosphamide | Bacterial pneumonia | Mortality | Bone marrow | Transplantation | Antineoplastic agents | Cancer
Journal Article